Emeka Okereke’s biography, fact, career, awards, net worth and life story

Intro Nigerian visual artist
Is Photographer
From Nigeria
Type Arts
Gender male
Birth

1980, Aba, Nigeria

Age 41 years

Emeka Okereke (born 1980) is a Nigerian photographer, filmmaker, writer and visual artist who lives and works in Lagos and Berlin.

Okereke is the cofounder of the Invisible Borders Trans-African Organisation

In 2018, he received Chevalier des Arts et Lettres from the Government of France.

Education

Emeka received a Master’s from the École nationale supérieure des Beaux-Arts de Paris (The National Superior school of fine arts of Paris) in 2008.

Career

In 2009, Okereke founded The Invisible Borders Trans-African Organisation, a collective of artists whose projects include the Invisible Borders Trans-African Road Trip and The Trans-African, a journal of African arts and visual culture.

His installation ‘A Trans-African Workspace’, was exhibited at the 56th Venice Biennale in 2015.

In summer of 2018, Okereke guest lectured at the Summer Academy of Fine Arts, Salzburg, Austria.

In 2018, he was awarded Chevalier De l’Ordre Des Arts et Des Lettres (Knight of the Order of Arts and Letters) from the French Government, in recognition of his significant contributions to the arts in Africa and Europe.

Selected exhibitions

Solo exhibitions

  • 2018: “Exploring a Void”. Salzburger Kunstverein, Salzburg Austria (Solo Exhibition)
  • 2008 Bagamoyo – Photography and the Useful Space / Maputo-Catembe – Maputo, Mozambique

Group exhibitions

  • 2017 * Collective Thinking, For Freedoms / Aperture Foundation – New York, United States
  • 2017 * Collectivism. Collectives and Their Quest For Value / Amsterdam Photography Museum (Foam) – Amsterdam, Netherlands
  • 2018: “Whose Land Have I Lit on Now?”, Savvy Contemporary Berlin
  • 2016 * No Borders / Gallery Dominique Fiat, – Paris, France
  • 2016 * Unseen Art Photo Fair / Unseen Amsterdam – Amsterdam, Netherlands
  • 2015 * 56th Venice Biennale / Venice Biennale – Venice, Italy

Publications

  • 2018 * Countering Western Hegemony Through Trans-African Exchange
  • 2017 * Africulture- Le Grand Palais n’aurait pas pu être construit sans l’exploitation coloniale de l’Afrique
  • 2017 * ContemporaryAnd : The Neighbour-Hood Project
  • 2016 * Trans-Africanism: An Urban Essay in The New African Magazine
  • 2015 * Black Portraitures: Whose Black Is it? in Minor Literatures
  • 2013 * Artscape by Al Jazeera- Emeka Okereke: Invisible Borders
  • 2013 * Okay Africa- Emeka Okereke on Photography And a World of Possibilities

Awards and honours

2018 – Chevalier De l’Ordre Des Arts et Des Lettres (Knight of the Order of Arts and Letters)

2016 Nominee, Prix Elysée for Photography (2016–2018)

2016 Long list nominee, Prix Pictet, 2016

2009 Artist of the Year, The Future Awards Africa

2008 Winner, Visa Pour la Creation for project “Bagamoyo”, Maputo Mozambique

2004 TV5, Paris Prize for Best Photography at the Exhibition “Made in Africa”, Milan Italy.

2003 Best Young Photographer of the 5th Festival of photography. Bamako, Mali.

You May Also Like

Randal Kirk’s net worth, biography, fact, career, awards and life story

Randal Kirk net worth: Randal Kirk is an American businessman who has an estimated net worth of $3.6 billion dollars. Born in Pleasonton, California, Randal Kirk moved around a great deal as a child, since his father was in the military. He earned his undergraduate degree from Radford University in Economics, and then went on to earn a law degree from the University of Virginia. In the mid-80s, he co-founded General Injectables and Vaccines, a Virginia-based pharmaceuticals company. The company spun off another pharmaceuticals company, based in Tennessee, called King Pharmaceuticals. The co-founders subsequently split, with each one taking a company. Mr. Kirk sold his portion for $65 million in cash. He then founded New River Pharmaceuticals in the mid-90s, and became CEO in 2001. He sold the company for $2.6 billion in 2007. He then launched a management investment firm, and another pharmaceutical company, called Clinical Data. He sold Clinical Data for $2.1 billion in 2011. He is currently focused on his new company, Intrexon.
Read More